Across TCGA pan-cancer cohorts, VPS54 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated VPS54 data layer compared with 24 for mass-spec protein and 11 for mutation status.
The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher VPS54 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated VPS54 expression acts as an unfavorable survival marker, although some lineages such as CCRCC show a favorable association.
LSCC and CCRCC are the cancer types where VPS54 mass-spec protein most reproducibly stratifies survival.